NinthBio is a software company serving Biotech. Our flagship product is "Homology Path", an application that designs the oligos for DNA synthesis. The value is how few oligos are needed to build a a group of similar DNA sequences.
Think of the DNA you would need to test for a protein engineering campaign, or to optimize the affinity of an antibody. All require similar but ultimately unique DNA. Our customers can improve their Design, Build, Test Learn Cycle by 15X all while decreasing their DNA spend 10 fold.
Researchers are rethinking where and what they are willing to explore given the power of Homology Path, opening the door for rapid and higher value discovery.
Want to see how this can help your initiatives; request a demo token to access the capabilities of Homology Path.
Company Details
- Employees
- 4
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.ninthbio.com/
Ninthbio Questions
Ninthbio's website is https://www.ninthbio.com/
Ninthbio's LinkedIn profile is https://www.linkedin.com/company/ninthbio
Ninthbio has
4 employees.
View email and phone details for 4
employees at Ninthbio.
Ninthbio's industry is
Biotechnology Research
Ninthbio's top competitors are
Quantum Sky Inc,
Teselagen Biotechnology,
Jorna Therapeutics,
Securecell Ag,
On-Chip Biotechnologies,
Molecular Devices,
Mekonos Inc.,
Fibrogen, Inc.,
Ganymede,
Rosetta Biosciences.
Ninthbio's categories are Biotechnology Research
Ninthbio's founding year is 2019
